Mga Batayang Estadistika
Manajer | Mark N. Lampert |
Profil Orang Dalam | BIOTECHNOLOGY VALUE FUND L P |
Nilai Portofolio | $ 3,009,160,043 |
Posisi Saat Ini | 55 |
Posisi Aktivis | 37 |
Pengajuan 13D/G
Ini adalah daftar pengajuan 13D dan 13G yang dibuat dalam setahun terakhir (jika ada). Klik ikon tautan untuk melihat riwayat transaksi lengkap. Baris berwarna hijau menunjukkan posisi baru. Baris berwarna merah menunjukkan posisi yang sudah ditutup.
Tanggal File | Formulir | Keamanan | Sebelumnya Saham |
Saat ini Saham |
ΔPersentase Saham | % Kepemilikan |
% ΔKepemilikan | |
---|---|---|---|---|---|---|---|---|
2025-08-20 | XFOR / X4 Pharmaceuticals, Inc. | 2,258,400 | 2,243,659 | -0.65 | 9.90 | 421.05 | ||
2025-08-18 | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 2,438,964 | 9,611,751 | 294.09 | 5.60 | 211.11 | ||
2025-08-14 | VIGL / Vigil Neuroscience, Inc. | 4,734,500 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-08-14 | UNCY / Unicycive Therapeutics, Inc. | 1,417,117 | 9.99 | |||||
2025-08-14 | VERV / Verve Therapeutics, Inc. | 6,904,050 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-08-14 | CBIO / Crescent Biopharma, Inc. | 0 | 1,387,863 | 9.99 | ||||
2025-08-14 | ITOS / iTeos Therapeutics, Inc. | 3,075,000 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-08-14 | IMUX / Immunic, Inc. | 8,902,972 | 9,785,178 | 9.91 | 9.99 | 0.91 | ||
2025-08-13 | VSTM / Verastem, Inc. | 4,706,551 | 5,720,831 | 21.55 | 9.99 | 0.00 | ||
2025-08-07 | EPIX / ESSA Pharma Inc. | 8,748,629 | 11,668,473 | 33.37 | 24.70 | 25.38 | ||
2025-07-21 | OVID / Ovid Therapeutics Inc. | 3,853,818 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-07-09 | NKTR / Nektar Therapeutics | 1,276,595 | 7.40 | |||||
2025-07-09 | CTMX / CytomX Therapeutics, Inc. | 8,089,795 | 11,538,462 | 42.63 | 6.80 | -31.93 | ||
2025-06-16 | PTGX / Protagonist Therapeutics, Inc. | 2,970,427 | 3,211,041 | 8.10 | 5.20 | 6.12 | ||
2025-05-20 | XOMA / XOMA Royalty Corporation | 2,983,026 | 2,590,303 | -13.17 | 21.60 | -14.62 | ||
2025-05-19 | ALLK / Allakos Inc. | 16,552,417 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-05-15 | CDTX / Cidara Therapeutics, Inc. | 1,093,499 | 1,252,441 | 14.54 | 9.99 | 0.00 | ||
2025-05-15 | GHRS / GH Research PLC | 10,400,158 | 8,827,712 | -15.12 | 14.20 | -28.96 | ||
2025-05-15 | FDMT / 4D Molecular Therapeutics, Inc. | 4,834,297 | 4,632,749 | -4.17 | 9.99 | 0.00 | ||
2025-05-15 | ELEV / Elevation Oncology, Inc. | 6,230,845 | 4,440,000 | -28.74 | 7.00 | -29.93 | ||
2025-05-15 | GLUE / Monte Rosa Therapeutics, Inc. | 4,393,210 | 5,660,132 | 28.84 | 9.20 | 27.78 | ||
2025-05-15 | SEPN / Septerna, Inc. | 2,452,024 | 4,396,124 | 79.29 | 9.90 | 80.00 | ||
2025-05-15 | TCRX / TScan Therapeutics, Inc. | 5,073,003 | 5,263,541 | 3.76 | 9.99 | 0.00 | ||
2025-05-09 | IVA / Inventiva S.A. - Depositary Receipt (Common Stock) | 8,545,499 | 8,545,499 | 0.00 | 6.10 | -32.22 | ||
2025-04-16 | THRD / Third Harmonic Bio, Inc. | 2,372,933 | 0 | -100.00 | 0.00 | -100.00 | ||
2025-02-14 | FBRX / Forte Biosciences, Inc. | 2,982,105 | 643,622 | -78.42 | 9.99 | 21.83 | ||
2025-02-14 | ETNB / 89bio, Inc. | 6,811,631 | 4,333,885 | -36.38 | 3.60 | -43.75 | ||
2025-02-14 | AVTX / Avalo Therapeutics, Inc. | 967,299 | 1,038,542 | 7.37 | 9.99 | 0.00 | ||
2025-02-14 | TYRA / Tyra Biosciences, Inc. | 4,661,194 | 3,944,194 | -15.38 | 7.80 | -11.36 | ||
2025-02-14 | VTGN / Vistagen Therapeutics, Inc. | 2,777,245 | 3,084,324 | 11.06 | 9.97 | -0.20 | ||
2025-02-14 | IKNA / Ikena Oncology, Inc. | 4,769,164 | 4,006,564 | -15.99 | 8.30 | -16.16 | ||
2025-02-04 | KURA / Kura Oncology, Inc. | 4,212,346 | 5,912,554 | 40.36 | 7.50 | 38.89 | ||
2025-01-29 | ENGN / enGene Holdings Inc. | 3,196,439 | 945,402 | -70.42 | 1.80 | -75.00 | ||
2025-01-06 | RAPT / RAPT Therapeutics, Inc. | 11,764,000 | 8.70 | |||||
2024-12-17 | PVLA / Palvella Therapeutics, Inc. | 1,168,117 | 9.99 | |||||
2024-12-04 | OLMA / Olema Pharmaceuticals, Inc. | 9,135,893 | 7,557,237 | -17.28 | 9.99 | -40.18 | ||
2024-11-14 | MTEM / Molecular Templates, Inc. | 537,426 | 672,767 | 25.18 | 9.99 | 0.00 | ||
2024-11-14 | ACIU / AC Immune SA | 14,571,236 | 19,522,436 | 33.98 | 19.70 | 33.11 | ||
2024-11-14 | VIRX / Viracta Therapeutics, Inc. | 3,833,785 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | LXRX / Lexicon Pharmaceuticals, Inc. | 24,435,632 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | STRO / Sutro Biopharma, Inc. | 3,347,946 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | RGLS / Regulus Therapeutics Inc. | 9,661,235 | 883,844 | -90.85 | 1.30 | -86.99 | ||
2024-11-14 | ANTX / AN2 Therapeutics, Inc. | 1,563,963 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | ZYME / Zymeworks Inc. | 5,870,000 | 4,607,935 | -21.50 | 6.50 | -30.11 | ||
2024-11-14 | CGEM / Cullinan Therapeutics, Inc. | 4,393,321 | 5,796,433 | 31.94 | 9.99 | 0.00 | ||
2024-11-14 | JANX / Janux Therapeutics, Inc. | 4,579,818 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | IDYA / IDEAYA Biosciences, Inc. | 3,479,043 | 1,409,993 | -59.47 | 1.70 | -67.92 | ||
2024-11-14 | DCTH / Delcath Systems, Inc. | 2,338,426 | 1,041,667 | -55.45 | 3.60 | -63.96 | ||
2024-11-14 | CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) | 8,774,570 | 0 | -100.00 | 0.00 | -100.00 | ||
2024-11-14 | ANNX / Annexon, Inc. | 7,000,000 | 9,027,778 | 28.97 | 8.40 | -5.62 | ||
2024-11-14 | MIRM / Mirum Pharmaceuticals, Inc. | 4,370,024 | 3,075,907 | -29.61 | 6.40 | -31.91 | ||
2024-10-31 | ELDN / Eledon Pharmaceuticals, Inc. | 4,326,710 | 6,293,282 | 45.45 | 10.50 | -41.34 | ||
2024-10-29 | MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) | 8,696,205 | 9,888,592 | 13.71 | 24.50 | 2.51 | ||
2024-10-08 | MLTX / MoonLake Immunotherapeutics | 21,751,284 | 19,751,284 | -9.19 | 31.40 | -9.25 | ||
2024-09-11 | CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock) | 6,260,311 | 0 | -100.00 | 0.00 | -100.00 |